Dr. John C. ShershowAdult ADHD PsychiatryCall (212) 265-4310
Menu

Key points

  • The Mydayis, Ritalin LA, Jornay PM and Dyanavel XR labels advise patients to avoid alcohol because it may cause a more rapid release of the drug.
  • In laboratory testing, the Concerta tablet showed no increased release in the first hour at alcohol concentrations up to 40%.
  • In a 2007 study of 20 healthy adults, alcohol raised peak blood levels of methylphenidate by about 40% and total exposure by about 25%.
  • The NIAAA lists possible heart problems with amphetamines and liver damage with atomoxetine among the risks of combining these medications with alcohol.
  • The Wellbutrin XL label says alcohol use should be minimized or avoided, citing reports of reduced alcohol tolerance and neuropsychiatric events.

Adults on ADHD medication have work dinners, weddings and weekends, and the question of whether one drink is a problem comes up often. The answer depends on the specific product, because some labels contain explicit alcohol warnings and others do not. This page sets out what the FDA labels (checked on DailyMed on October 19, 2026), a federal alcohol agency and research say. It does not give doses, and it is not advice to start, stop or change a medication. Your prescriber and pharmacist can answer the question for your exact product.

Problem one: some capsules release their drug faster

Extended-release products are built to release medication slowly over many hours. Laboratory tests with alcohol show that some designs can release much of their drug early, a problem called dose dumping. Others hold up. The labels differ:

ProductWhat the label says about alcohol
Mydayis (mixed amphetamine salts ER)Lab testing showed faster amphetamine release in 20% and, more noticeably, 40% alcohol. The label advises patients to avoid alcohol.
Ritalin LA (methylphenidate ER capsule)At 40% alcohol, 98% of the methylphenidate was released in the first hour in lab testing. The label advises patients to avoid alcohol.
Jornay PM (methylphenidate, taken in the evening)About 97% was released within 2 hours in 40% alcohol; no increase at 5% to 20% alcohol. The label advises patients to avoid alcohol.
Dyanavel XR (amphetamine ER)The liquid suspension showed dose-dumping potential in 40% alcohol; the tablets did not. The label advises patients to avoid alcohol.
Concerta (methylphenidate ER tablet)At alcohol concentrations up to 40%, no increased release in the first hour in lab testing.
Azstarys (serdexmethylphenidate and dexmethylphenidate)No clinically significant change in release at 5% or 40% alcohol in lab testing.
Qelbree (viloxazine ER)No significant effect with 4% or 20% alcohol; with 40% alcohol, drug levels went down rather than up.

Two cautions about this table. First, these are mostly test-tube results; several labels note that no study in people has measured the effect of alcohol on drug levels. Second, "no dose dumping" for a product only addresses how the capsule or tablet behaves. It does not mean alcohol and the drug are a safe pair in the body. For how these release systems work, see extended-release ADHD medications explained.

Problem two: alcohol changes what the drug does in the body

A 2007 study by Patrick and colleagues in Clinical Pharmacology and Therapeutics gave 20 healthy adults methylphenidate with and without alcohol. Alcohol taken 30 minutes before or after the medication raised the peak blood level of d-methylphenidate, which made up nearly all of the methylphenidate measured in blood, by about 40% and total exposure by about 25%. The combination also produced a new compound, ethylphenidate. Women reported a greater stimulant effect than men despite lower average blood levels.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) lists the harms of mixing alcohol with ADHD medications by drug:

  • Methylphenidate and dexmethylphenidate (Ritalin, Concerta, Focalin): dizziness, drowsiness and impaired concentration.
  • Amphetamine, dextroamphetamine and lisdexamfetamine (Adderall, Dexedrine, Vyvanse): possible increased risk for heart problems.
  • Atomoxetine (Strattera): liver damage.

The same NIAAA publication notes that alcohol affects women differently, generally reaching higher blood levels than in men from the same amount, and that some medicines contain up to 10 percent alcohol, with cough syrups and laxatives among the highest. Many cough, cold and allergy remedies also contain more than one ingredient that can react with alcohol, so reading the full ingredient list matters when you are already taking an ADHD medication.

Nonstimulants and off-label options

  • Guanfacine ER (Intuniv). The label lists sleepiness and sedation as common and advises patients to avoid use with alcohol. Its Medication Guide says alcohol may make sleepiness or dizziness worse.
  • Bupropion (Wellbutrin XL). The label reports rare neuropsychiatric events and reduced alcohol tolerance in people drinking during treatment, and says alcohol "should be minimized or avoided." Excessive alcohol use raises seizure risk, and bupropion is contraindicated during abrupt withdrawal from alcohol. See the bupropion page.
  • Atomoxetine (Strattera). The current label has no specific alcohol section, but it warns about rare severe liver injury, and the NIAAA lists liver damage as a risk of combining it with alcohol.

Drinking history matters before the first prescription

Stimulant Medication Guides ask patients to tell their provider if they have ever abused or been dependent on alcohol, prescription medicines or street drugs. That question is part of the misuse risk assessment the FDA's 2023 boxed warning update asks prescribers to make. Answering honestly helps the prescriber weigh the options.

On the broader question of whether ADHD treatment raises or lowers substance problems, a 2017 study by Quinn and colleagues in the American Journal of Psychiatry analyzed insurance claims for nearly 3 million adolescents and adults with ADHD. During months on ADHD medication, men had 35% lower odds and women 31% lower odds of emergency visits related to substance use than during months off medication. It was an observational study, so it shows association, not cause. More on this is in ADHD and substance use and misuse and addiction risk. New Jersey readers asking about cannabis can see ADHD medication and cannabis in New Jersey.

Driving

The NIAAA warns that small amounts of alcohol can make driving dangerous and that mixing alcohol with certain medicines raises that risk further. The Strattera, Qelbree and Intuniv Medication Guides already caution against driving until you know how the medication affects you. See ADHD and driving in New York.

Questions to ask your prescriber or pharmacist

  1. Does the label for my exact product, brand or generic, say anything about alcohol?
  2. Is my product one of the extended-release designs that released faster in alcohol testing?
  3. Given my health history, are there specific risks for me in combining alcohol with this medication?
  4. Do any of my other medications, such as bupropion or a sleep aid, add to the risk?

When to contact the prescriber, and when to call 911

  • Ask the prescriber or pharmacist what the label for your exact product says about alcohol, especially if you take a capsule listed above.
  • Contact the prescriber if you are drinking more than you intend, if drinking is affecting your sleep or mood, or if you notice yourself using alcohol to come down from the medication in the evening.
  • Go to the emergency room for chest pain, shortness of breath or fainting, which stimulant Medication Guides say need care right away. If someone may have taken too much medication, call Poison Help at 1-800-222-1222 or go to the nearest emergency room.
  • Call 911 if someone is confused, cannot stay awake, is vomiting, has a seizure, or is breathing slowly or irregularly after drinking. The NIAAA lists these as signs of alcohol overdose and says not to wait for every symptom to appear.

Any change to how or whether you take the medication around drinking is a conversation for the prescriber, not a solo decision. Dr. Shershow's evaluation asks about substances as part of the health history, and medication management continues by secure video; see adult ADHD treatment.

Questions

Can I drink alcohol on Adderall or Vyvanse?

The NIAAA lists a possible increased risk for heart problems when alcohol is combined with amphetamine, dextroamphetamine or lisdexamfetamine. The Mydayis label, a long-acting amphetamine, advises patients to avoid alcohol. Ask your prescriber what applies to your product and your health.

Can I drink alcohol on Ritalin or Concerta?

A 2007 study found alcohol raised peak methylphenidate levels by about 40%, and the NIAAA lists dizziness, drowsiness and impaired concentration. The Ritalin LA label advises avoiding alcohol because it can speed up release; Concerta's tablet showed no early release in lab tests, but that does not make drinking risk-free.

What is dose dumping?

It means an extended-release product releases much of its drug at once instead of over many hours. In lab tests, alcohol caused this with Ritalin LA, Jornay PM, Mydayis and the Dyanavel XR suspension, and their labels advise avoiding alcohol.

Is it safe to drink on Strattera?

The current Strattera label has no specific alcohol section, but it warns about rare severe liver injury, and the NIAAA lists liver damage as a risk of combining atomoxetine with alcohol. Discuss your drinking with your prescriber.

Does ADHD medication increase the risk of alcohol problems?

A large 2017 claims study found lower odds of substance-related emergency visits during months on ADHD medication than months off it. It was observational, so it cannot prove cause. Stimulants still carry a boxed warning about misuse and addiction.

Sources

  1. DailyMed: Mydayis (mixed amphetamine salts) extended-release capsules prescribing information, Takeda (label effective April 30, 2026)
  2. DailyMed: Ritalin LA (methylphenidate hydrochloride) extended-release capsules prescribing information, Novartis (label effective September 23, 2025)
  3. DailyMed: Jornay PM (methylphenidate hydrochloride) extended-release capsules prescribing information, Ironshore (label effective October 3, 2025)
  4. DailyMed: Dyanavel XR (amphetamine) extended-release oral suspension and tablets prescribing information, Tris Pharma (label effective February 24, 2026)
  5. DailyMed: Concerta (methylphenidate hydrochloride) extended-release tablets prescribing information and Medication Guide, Janssen (label effective April 20, 2026)
  6. DailyMed: Azstarys (serdexmethylphenidate and dexmethylphenidate) capsules prescribing information (label effective May 11, 2026)
  7. DailyMed: Qelbree (viloxazine) extended-release capsules prescribing information and Medication Guide, Supernus (label effective October 5, 2026)
  8. DailyMed: Intuniv (guanfacine) extended-release tablets prescribing information, Takeda (label effective June 23, 2025)
  9. DailyMed: Wellbutrin XL (bupropion hydrochloride) extended-release tablets prescribing information (label effective February 10, 2026)
  10. DailyMed: Strattera (atomoxetine) capsules prescribing information and Medication Guide, Eli Lilly (label effective June 30, 2026)
  11. Patrick et al., Clinical Pharmacology and Therapeutics 2007;81(3):346-353: Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics
  12. National Institute on Alcohol Abuse and Alcoholism: Harmful interactions, mixing alcohol with medicines
  13. Quinn et al., American Journal of Psychiatry 2017;174(9):877-885: ADHD medication and substance-related problems
  14. US Food and Drug Administration: FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions (May 11, 2023)
  15. National Institute on Alcohol Abuse and Alcoholism: Understanding the dangers of alcohol overdose

Concerned about side effects?

Medication management includes regular follow-up to check how treatment is working and adjust it. Call, or leave your number and the office will call you.

Prefer a call back?

Leave your number and the office will call you to talk about scheduling.

No health details needed. Not for emergencies: call or text 988, or call 911.

Request a ConsultCall (212) 265-4310